Medicine’s Daniel Spratt and Jonathan Shoag weighs in on high cost of focal therapy for prostate cancer
Focal therapy for prostate cancer: Evidence-based or oversold? Medscape: Daniel Spratt, professor of radiation oncology, and Jonathan Shoag, associate professor...